SCRG1 and neoplasm: Furthermore, we verified that in-miR26a could counteract the protective effect of sh-lincSCRG1, including inhibition of tumour growth (tumour size or weight) in a xenograft tumour model and inhibition of lung metastasis in a mouse model.